Article

Oncology Nurse Linda Casey Offers Advice to Cancer Caregivers

Oncology nurse Linda Casey encourages caregivers to be vigilant in watching for signs and symptoms of anything abnormal in the patient, such as certain side effects.

Oncology nurse Linda Casey encourages caregivers to be vigilant in watching for signs and symptoms of anything abnormal in the patient, such as certain side effects. "They know them obviously better than any doctors or nurses know them," she says.

Some types of chemotherapy can lower white blood cell counts, which can increase the risk of infection. Other therapies can affect blood pressure and other side effects that should be reported to the patient's medical team.

"If anything seems off to you, I think that it's very important that you always call the doctor and follow up," Casey says. "Don't be afraid of bothering anybody."

It's also important to talk with the patient's medical team on what symptoms to monitor for and what should be done if the caregiver suspects they may be occurring.

Casey recommends caregivers set up a routine to check the patient's temperatures, blood pressures, and other vitals that may signal that something is wrong.

"Any little deviation from normal can indicate a problem that can turn into something that you wouldn't want to encounter," she says.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of man with text.
Dr. Breelyn Wilky explains how vague symptoms and testing challenges delay GIST diagnoses
Mark Daniels, an 83-year-old veteran and former fighter pilot, was shocked by his lymphoma diagnosis because he maintained exceptional physical fitness.
Image of man with text.
Image of women, with text.
Image of Dr. with text.
Daniel Jernazian, who beat cancer twice, credits his sports mindset for survival and calls it winning his ‘life World Championship’.
Patients in rural or underserved areas may have worse outcomes, highlighting the need for early support to address care access barriers.
Image of man with text.
Dr. Emre Yekedüz discusses how ASCO 2025 highlights precision medicine, biomarkers and the gut microbiome as keys to advancing kidney cancer care.
Related Content